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a b s t r a c t
Naturally derived polymers have been extensively used in scaffold production for cartilage tissue engi-
neering. The present work aims to evaluate and characterize extracellular matrix (ECM) formation in
two types of chitosan-based scaffolds, using bovine articular chondrocytes (BACs). The influence of these
scaffolds’ porosity, as well as pore size and geometry, on the formation of cartilagineous tissue was stud-
ied. The effect of stirred conditions on ECM formation was also assessed. Chitosan-poly(butylene succi-
nate) (CPBS) scaffolds were produced by compression moulding and salt leaching, using a blend of 50%
of each material. Different porosities and pore size structures were obtained. BACs were seeded onto CPBS
scaffolds using spinner flasks. Constructs were then transferred to the incubator, where half were cul-
tured under stirred conditions, and the other half under static conditions for 4 weeks. Constructs were
characterized by scanning electron microscopy, histology procedures, immunolocalization of collagen
type I and collagen type II, and dimethylmethylene blue assay for glycosaminoglycan (GAG) quantifica-
tion. Both materials showed good affinity for cell attachment. Cells colonized the entire scaffolds and
were able to produce ECM. Large pores with random geometry improved proteoglycans and collagen type
II production. However, that structure has the opposite effect on GAG production. Stirred culture condi-
tions indicate enhancement of GAG production in both types of scaffold.
! 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
1. Introduction
There are four major types of cartilage, which can be distin-
guished by their specific constitutive components: hyaline carti-
lage, fibrocartilage, elastic cartilage and costochondral cartilage
[1]. Hyaline articular cartilage is the most abundant type in the
body, composed of one cell type (the chondrocyte) dispersed in
an abundant extracellular matrix (ECM). ECM is composed mainly
of collagen type II and a large proteoglycan, aggrecan [1,2]. The
ECM provides most of the functional properties associated with
hyaline cartilage, including resistance to compression and provi-
sion of low friction articulating surfaces in the joints. Injuries to
cartilage are often painful and may severely affect movement.
Unfortunately, articular cartilage has a relatively poor capacity
for self-repair (related to the lack of a direct blood supply), and car-
tilage injury is frequently associated with the onset of chronic
problems, including osteoarthritis [1,3].
Currently, there is no agreed method of restoring fully damaged
cartilage [4]. Current therapies include abrasion arthroplasty, sub-
chondral drilling, prosthetic joint replacement and, ultimately,
transplantation of autologous chondrocytes or tissues [4,5]. How-
ever, these treatments do not constitute a complete recovery for
the patient and, in most cases, persistent problems of donor site
morbidity, limitations of patient mobility and consequent disabil-
ity, loss of implants and limited durability of the prosthetics
[2,4–6] are observed.
Tissue engineering represents a promising approach for the re-
pair of articular cartilage, but there is still no ideal scaffold for this
approach. Chitosan/polyesters appear to offer several advantages
in this field.
In recent years, natural-based polymers, such as, for example,
chitosan, have been studied extensively [7–11]. Chitosan is a deriv-
ative of chitin, obtained by deacetylation of this biopolymer [12].
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Chitin is the second most abundant polysaccharide in nature, being
found usually in crustaceans’ shells. Chitosan is a linear polysac-
charide with a structure similar to glycosaminoglycans (GAGs)
present in native cartilage ECM [13]. This property is extremely
important for cartilage tissue engineering, since it allows the
development of several types of scaffold. Another interesting prop-
erty of chitosan is that it can be moulded into various shapes [14]
and allows for the formation of different pore sizes structures [12].
It has an intrinsic antibacterial activity and high biocompatibility
[13]. Chitosan has been used in several blends to produce many
types of scaffold, e.g. hydrogels [15,16], porous scaffolds [11], ami-
no acid immobilization [9] or drug delivery [17]. The authors’
group has developed innovative blends of synthetic polymers with
chitosan [7,8,18,19], which have been developed for biomedical
applications such as bone [20–22] or cartilage [23,24]. Studies have
been conducted preparing chitosan-based scaffolds aimed at carti-
lage regeneration, which showed evidence of favourable responses
in vitro [20,21,24–26]. As for in vivo studies, a high degree of bio-
compatibility of chitosan scaffolds has been shown in mice [13].
Another study, conducted in rabbits, observed hyaline-like tissue
after 24 weeks of implantation [15]. Recently, the basis for a carti-
lage engineering model in a large animal has been established
using Merino sheep and chitosan-based scaffolds [27]. Using ovine
MSC combined with chitosan and TGF-b3, histological analysis re-
vealed chondrocyte-like cells surrounded by a hyaline-like carti-
laginous matrix that was well integrated with the host cartilage
[27]. The bio-functionality of chitosan scaffolds produced by parti-
cle aggregation was tested in rats in vivo, which showed promising
results in terms of connective tissue in-growth and neo-vasculari-
zation [28].
In the current study, a bovine chondrocyte model was used to
establish primary cultures, and the formation of ECM in chito-
san/polyester-based scaffolds was evaluated. Two types of scaf-
folds with different pore sizes and pore geometries were studied,
and ECM deposition on both types of scaffolds was evaluated. In
addition, different culture conditions were used, namely static
vs. dynamic, in order to establish the most suitable method for
obtaining hyaline cartilage tissue in vitro.
2. Materials and methods
2.1. Scaffolds production
A chitosan-poly(butylene succinate) (CPBS) (50/50 wt.%) blend
was produced and processed into scaffolds using a methodology
based on compression moulding followed by salt leaching, as pre-
viously described [8,18]. Common salt (NaCl) was used as the poro-
gen agent. Two different groups of scaffolds were produced: one
using 80 wt.% salt with particles size between 63 and 125 lm (80
CPBS). The second group of scaffolds was produced using 60 wt.%
salt with particle size between 250 and 500 lm (60 CPBS). In both
cases, salt and blend were loaded into a mould, heated and com-
pression-moulded into large discs. Discs were sliced to obtain
5 mm cubes. These cubes were immersed in distilled water to
leach out the salt over 6 days. Water was changed every day to
facilitate the complete dissolution of the porogen agent. At the
end of the procedure, the cubes were dried until a constant weight
was obtained. The resulting scaffolds were characterized, and will
be referred to as 80% porosity or 60% porosity.
2.2. Isolation of bovine articular chondrocytes (BACs)
Isolation of BACs was performed according to a method previ-
ously reported [29]. Full thickness hyaline cartilage was harvested
from bovine metacarpophalangeal joint. The skin was removed,
and the jointwas transferred to a laminar air hood. Cartilagewasdis-
sected in small full-depth pieces and washed twice with PBS buffer
(Sigma D-8537). Then it was digested with 0.25% (w/v) of trypsin
solution (SigmaE-5134) for30 minat 37 "Cona rotator. The solution
was removed, cartilage was washed again in PBS buffer and then
incubated in a collagenase type I solution (2 mg ml!1) (Sigma E-
0130) overnight at 37 "C on a rotator (Stuart mini orbital shaker
SSM1). The following day, cells were washed twice with PBS,
counted and plated at a density of 2 " 106 cells per Petri dish. Cells
were cultivated with expansion medium: Dulbecco’s modified Ea-
gle’s medium (DMEM; high glucose) (Sigma D-5671), containing
10 mM Hepes buffer (Sigma H-0887), l-alanyl-l-glutamine (Sigma
G-8541), non-essential aminoacids (Sigma M-7145) 10,000 uni-
ts ml!1 penicillin, 10,000 lg ml!1 streptomycin (Sigma P-0781),
10% foetal calf serum(BioseraS1810)and10 ng ml!1 basicfibroblast
growth factor (bFGF) (PeproTech100-18B). The culturemediumwas
changed twice a week, and cells were expanded until passage 2.
2.3. Bovine articular chondrocyte (BAC) culture on chitosan-based
scaffolds
BAC seeding was performed dynamically in spinner flasks. Cells
were harvested, counted and resuspended in expansion medium.
Twentyscaffoldswereused ineachexperiment, for each typeof scaf-
fold. Materials were seeded with a cell suspension containing
6.5 " 105 cells per scaffold. Seedingwas performed in spinner flasks,
using a magnetic stirrer placed inside an incubator at 37 "C in order
to allow cell penetration into the material’s porous structure. After
cell seeding was complete, constructs were removed from spinner
flasks. Two experimental conditions were set: dynamic and static.
For dynamic culture conditions, half the constructs were incubated
at 37 "C on a rotator at 60 rpm. For static conditions, constructswere
left to culture statically inside the incubator. The culture medium
was changed every 3 days. At this stage, the culture medium used
was differentiation medium (expansion medium without bFGF and
with 1 mg ml!1 of insulin (Sigma Co.) and 1 mg ml!1 of ascorbic
acid) (Sigma A-4544). Samples were taken at different time points:
1, 2, 3 and 4 weeks of culture.
2.4. Microcomputed tomography (lCT)
Microcomputed tomography (lCT) equipment (SkyScan, Bel-
gium) was used as a non-destructive technique for very detailed
analysis of the morphology of the developed scaffolds. Four scaf-
folds of each condition were scanned in high-resolution mode of
8.7 lm x/y/z and an exposure time of 1792 ms. The energy param-
eters defined in the scanner were 63 keV with a current of 157 lA.
Isotropic slice data were obtained by the system and reconstructed
into two-dimensional (2D) images. These slice images were com-
piled and analysed to render three-dimensional (3D) images and
obtain quantitative architecture parameters. A lCT analyser and
a lCT Volume Realistic 3D Visualization, both from SkyScan, were
used as image processing tools both for lCT reconstruction and to
create/visualize the 3D representation. Regions of interest
(4.5 " 4.5 mm squares) were selected in each slice image, and a
threshold was set to eliminate background noise. This threshold
(to distinguish polymer material from pore voids) was chosen
and maintained constant for all the scanned specimens and sam-
ples. The threshold was also inverted to obtain pore volume and
to analyse the pore morphology.
2.5. Scanning electron microscopy
For scanning electron microscopy (SEM) analysis, constructs
were collected at every time point. They were washed in sterile
PBS and immersed in 3% glutaraldehyde (Sigma G-5882) with
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0.1 M cacodylate buffer pH 7.4 (AGAR R1103) at room temperature
for 30 min. Afterwards, they were washed in PBS buffer three times
to remove all glutaraldehyde from the surface. Then constructs
were submerged in osmium tetraoxide and left for 2 h. Finally, they
were dehydrated in alcohol and left to air dry. The samples were
splutter-coated with gold and analysed by SEM. Two different
scanning electron microscopes were used for this work: a Philips
XL-20 and a Leica Cambridge S360 (Leica Cambridge, Cambridge,
UK).
2.6. Histological analysis (hematoxylin–eosin, toluidine blue, alcian
blue)
Samples were collected at the end of the experiment (4 weeks
of culture) and embedded in OCT (OCT compound BDH, Gurr) in or-
der to make them suitable for cryosectioning, and stored at !20 "C.
Sections were cut at 8 lm and placed on microscopy slides. A fresh
4% paraformaldehyde (Sigma P-6148) solution in PBS buffer was
prepared, filtered and cooled down for fixation of the slides. Slides
were fixed for 30 min at 4 "C, washed twice in distilled water and
left to air dry overnight. Slides were subsequently stored at 4 "C
until used for staining procedures. Hematoxylin and eosin (H&E)
staining was conducted in an automatic machine fume cupboard
(X219/E11/LEV1). In this procedure, sections were washed in run-
ning tap water for 5 min, and then dipped in 1% acid alcohol for 5–
10 s. Sections were washed again in tap water and stained in eosin
for 10 min. Another wash with tap water was performed for 5 min,
and sections were afterwards dehydrated through alcohols. They
were cleared in xylene and mounted in DPX (BDH 36029 2F). Tolu-
idine blue staining was performed on a selection of the sections.
The staining solution was prepared by dissolving 1% of toluidine
blue (Sigma T-0394) in distilled water containing 0.5 g of sodium
borate, followed by filtering. One drop of this solution was added
to each section for 2–3 s. Then, sections were rinsed with distilled
water and allowed to air dry overnight. Sections were cleared and
mounted as described previously. Alcian blue staining was per-
formed by rinsing the sections in 3% acetic acid and incubating
them in 1% alcian blue solution (Sigma A-3157) for 18 h. After that,
the stain was poured off, and sections were counterstained with
aqueous neutral red (Sigma N-6634) for 1 min. Sections were
washed with water, left to air dry and then rinsed in absolute alco-
hol, cleared and mounted as described previously.
2.7. Immunolocalization of type I and II collagens
Immunolocalization of type I and type II collagens was per-
formed in fixed sections. Sections were washed in PBS and pre-
treated with 10 mg ml!1 hyaluronidase (Sigma Co.) in PBS for
30 min at 37 "C and with 2 mg ml!1 pronase (Fluka/Sigma Co.)
again for 30 min at 37 "C. Then, sections were washed in PBS,
and endogenous peroxidase activity was quenched with 3% hydro-
gen peroxide in 50% methanol (BDH 101586 6B) for 5 min. Sections
were washed in Tri-buffered saline (TBS) solution and blocked with
3% BSA (Sigma A-2153) in TBS/Tween 20 (Sigma Ultra P-7949) for
1 h to avoid non-specific staining. Sections were then incubated
with primary antibodies (collagen type I and collagen type II) (goat
anti-type I collagen UNLB 1310-01 and goat anti-type II collagen
UNLB 1320-01) overnight at 4 "C in a humidified atmosphere.
The next day, sections were washed once with high salt wash solu-
tion and twice in TBS/Tween 20 for10 min each and then incubated
with secondary antibody from the kit for 1 h at room temperature,
again in a humidified atmosphere. The remaining protocol is as de-
scribed in the Vectastain Elite ABC Kit PK-6105 (Vector Laborato-
ries Ltd., UK) and in the Vector DAB Kit (Vector Laboratories Ltd.,
UK). Slides were washed in water for 5 min and then counter-
stained with haematoxylin for nuclei visualization. Then slides
were mounted in DPX. Controls were performed using normal goat
serum instead of primary antibodies, which was also included in
the kit.
2.8. Dimethylmethylene blue assay for glycosaminoglycan (GAG)
quantification
For this assay samples were collected at 4 weeks of culture,
freeze/dried overnight and then digested. This digestion allowed
the separation from the scaffold of the ECM formed. Digestion solu-
tion was prepared by adding papain (Sigma P-4762) and N-acetyl
cysteíne (Sigma A-8199), to obtain the final concentrations of
0.05% and 0.096%, respectively, to 50 ml of digestion buffer
(200 mM of phosphate buffer containing 1 mM EDTA (Sigma E-
5134), pH 6.8). Samples were placed in 1.5 ml tubes and incubated
with 600 ll of the relevant solution, overnight at 60 "C. Afterwards,
samples were centrifuged in a bench centrifuge at 13,000 rpm for
10 min. Supernatant was collected and stored at !20 "C until the
GAG assay was performed. Solutions for this assay were prepared
as follows. Dimethylmethylene blue (DMB) stock solution was pre-
pared by dissolving 16 mg DMB powder in 900 ml of distilled
water containing 3.04 g glycine and 2.73 g NaCl. This was mixed
for 2 h, covered with aluminium foil. pH was adjusted to 3.0 with
HCl and volume to 1 l. The solution was stored at room tempera-
ture covered with aluminium foil. Chondroitin sulphate (Sigma
C-8529) solution was prepared in water, in a 5 mg ml!1 stock solu-
tion and kept refrigerated. This solution was diluted with water,
resulting in 5 unit increments from 0 to 50 lg ml!1, in order to
make a standard curve. Samples were also diluted as appropriate
with distilled water. To a 96 well plate, 20 ll of water was added
as a blank. The same quantity of chondroitin sulphate diluted solu-
tion was added in duplicate, and the same was performed with all
the samples. To each well, 250 ll of DMB solution was added in a
multichannel pipette, and the optical density was measured in a
microplate reader at 530 nm. Scaffolds without seeded cells were
used as controls.
2.9. Reproducibility of the experiments
Each scaffold seeding was performed three times with cells iso-
lated from a different animal.
2.10. Statistical analysis
Data from triplicates of GAG quantification are present as aver-
age ± standard errors. One-way analysis of variance in conjunction
with Tukey’s test was performed on the GAG assay results.
3. Results
2D and 3D lCT images from both groups of scaffolds show dif-
ferences between their morphology (Figs. 1 and 2). Scaffolds of 60
CPBS (Fig. 1A) show fewer pores than 80 CPBS scaffolds (Fig. 1B), as
expected. Scaffolds of 60 CPBS presented smaller pores. Correlo
et al. recently produced and characterized these two types of scaf-
folds in terms of porosity, pore size andmechanical properties [18].
The 80 CPBS scaffolds were shown to have 78.6 ± 2.5% porosity,
and a pore size of 276.8 ± 52.5 lm. However, 60 CPBS scaffolds
were shown to have lower porosity (57.7 ± 6.6%), as well as a smal-
ler pore size (199.3 ± 5.3 lm) [18].
Pore geometry was also different in both compositions. As can
be observed in the 2D lCT images, pores of the 60 CPBS scaffolds
have a geometrically defined shape (similar to the salt structure),
and seem to be homogeneously distributed throughout the scaf-
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folds. In contrast, the pores of the 80 CPBS scaffolds are randomly
distributed and do not present a specific shape.
The SEM micrographs presented in Fig. 3 show the distribution
of cells in the seeded scaffolds throughout the period of the exper-
iment. It can be observed that the chondrocytes colonized the
entire scaffold in both types of material. Cells kept their round-
shaped morphology, typical of chondrocytes, in both static culture
(Fig. 3A–D; I–L) and stirred culture conditions (Fig. 3E–H; M–P).
Nevertheless, it was observed that the colonization of 60 CPBS scaf-
folds appeared slower than in 80 CPBS scaffolds in both culture
conditions.
The colonization of the scaffolds by cells was shown by H&E
staining (Fig. 4A, D, G and J). H&E staining showed more cells cov-
ering the surface of the 80 CPBS scaffolds than in the 60 CPBS ones.
Consequently, more proteoglycans were observed, as shown in the
results of toluidine blue (Fig. 4H and K) and alcian blue (Fig. 4I and
L) staining. This observation applies for both culture conditions
(static and dynamic). It is important to highlight the alcian blue
staining results. The staining in the 80 CPBS scaffolds seems to
be stronger and again cover more surface area than that obtained
for 60 CPBS scaffolds, in both culture conditions. These results indi-
cate a higher concentration of sulphated proteoglycans in these
samples.
The results of immunolocalization of collagens type I and type II
in both groups of scaffolds are presented in Fig. 5. Cells seeded into
60 CPBS scaffolds produced both collagen type I and collagen type
II (Fig. 5A–F), in both static (Fig. 5B and C) and stirred culture con-
ditions (Fig. 5D and F). In contrast, collagen type I was discrete in
the section of 80 CPBS scaffolds (Fig. 5H and K), whereas collagen
type II synthesis was revealed in all samples (Fig. 5I and L).
GAGs presented in both types of scaffolds were quantified by
the DMB assay, and the results are presented in Fig. 6. Significantly
higher GAG production in 60 CPBS scaffolds was detected in com-
parison with 80 CPBS scaffolds. Stirred culture conditions signifi-
cantly (P < 0.05) enhanced GAG production in both types of
scaffolds when compared with static culture conditions. There
was a statistical difference in GAG production in 60 CPBS scaffolds
when cultured in stirred conditions compared with the data ob-
Fig. 1. 2D lCT images of (A) 60 CPBS scaffolds, (B) 80 CPBS scaffolds, obtained by compression moulding and salt leaching. The images highlight the geometry of the pores
obtained.
Fig. 2. 3D lCT images of (A) 80 CPBS scaffolds, (B) 60 CPBS scaffolds, obtained by compression moulding and salt leaching. The images highlight the porosity of both scaffolds.
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tained for static culture conditions. For 80 CPBS scaffolds, GAG pro-
duction in stirred culture conditions was higher, but not statisti-
cally different.
4. Discussion
The structure of pores is one important factor in tissue regener-
ation. The growth of some specific cell types in injured sites is
dependent on optimal pore size and geometry [30]. Pore size af-
fects cell response in terms of attachment, growth and prolifera-
tion [31]. Variation in pore size also affects the mechanical
stability of constructs, and this is an important factor when
implanting them in load-bearing areas as well as evaluating the
construct response to mechanical stimuli in bioreactors [32]. In
particular, permeability affects the shear stresses inside the con-
struct [33], which is a stimulus for cellular differentiation or func-
tional adaptation of the construct during the implant. Furthermore,
the mechanical environment in the tissue has a controlling influ-
ence on tissue differentiation [33]. For in vivo implantation, cells
need to be expanded in vitro to a sufficient number in order to gen-
erate a construct with certain mechanical stability [34]. Further-
more, upon implantation, the scaffolds and cells will be subjected
to the action of synovial fluid flow in the joint. The fluid flow is be-
lieved to facilitate cell migration and promote positive signals by
mechanotransduction to the cells. Therefore, the dynamic culture
conditions may support high seeding densities and help cells to
grow, proliferate and produce ECM. Those conditions are also be-
lieved to lead to more stable constructs, and therefore may en-
hance the construct integration within the tissue at the implant
site. In work by Gotterbarm et al. [35], two-layered biomaterials
were implanted in osteochondral defects created in the trochlear
groove of Göttinger minipigs. They observed cellular migration
and cell attachment, as well as matrix production. These authors
claim that this cellular filling and attachment was fostered by
the porous character of the biomaterials, and led to an increased
amount of repaired tissue [35].
In previous work, Correlo et al. produced and characterized sev-
eral scaffolds produced from different blends of chitosan and syn-
thetic polyesters, including the CPBS scaffolds studied in the
present work [18]. A higher range of different types of scaffolds
were produced by compression moulding and salt leaching, using
different salt sizes to induce small and large pores. Curiously, small
salt sizes originated larger pores, owing to the aggregation of the
salt particles [18]. The scaffolds from the blend CPBS (50%/50%)
were chosen based on cytotoxicity and direct contact tests previ-
ously performed (data not shown). It was intended to determine
the effect of the pore size and shape on the production of ECM
by BAC.
In work by Spiteri et al., it was shown that substrate porosity
enhanced BAC attachment, growth and formation of cartilage
Fig. 3. BAC growth morphology in CPBS scaffolds throughout the time course of the experiment: (A–H) results for static (A–D) and dynamic (E–H) cultures in 60% porosity
scaffolds; (I–P) results for static (I–L) and dynamic (M–P) cultures in 80% porosity scaffolds. Different magnifications were used to highlight cell morphology.
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in vitro [31]. In the present work, scaffold pore morphology seems
to affect BAC attachment and colonization equally. Globally, it is
observed that cells attached and colonized both scaffolds. This
observation is similar to that obtained when rabbit chondrocytes
were seeded onto chitosan-based hyaluronic acid hybrid polymer
fibers. In that study, cell proliferation had no significant difference
between three groups of scaffolds with different pore sizes [26].
Some studies have focused on the effect of pore size on chon-
drocyte performance. Cartilaginous tissue obtained on porous tita-
nium alloy discs with the smaller pore size was thicker and had
more proteoglycans in comparison with tissue obtained from discs
with larger pore sizes [36]. Another study by Nehrer et al. showed
that biosynthetic activity and chondrocyte phenotype were im-
proved in collagen matrices with smaller pores [37]. It has been
suggested that cell–cell interactions are enhanced in scaffolds with
small pore sizes, thus resulting in improved chondrocyte prolifer-
ation [37]. These studies lead to the conclusion that small pores
improve chondrogenesis. However, several other studies point in
the opposite direction. Griffon et al. determined that large inter-
connective pores improve the cellularity andmatrix content within
chitosan scaffolds [38]. In recent work, Lien et al. also showed that
articular chondrocytes of Wistar rats performed better in the group
of scaffolds with pore sizes between 250 and 500 lm in terms of
proliferation and ECM production [39]. In fact, the present findings
support these observations. Cells seeded into 60 CPBS produced
both collagen type I and collagen type II (Fig. 5A–F), indicative of
Fig. 4. Production of ECM in CPBS scaffolds at 4 weeks of culture: (A–F) results for static (A–C) and dynamic (D–F) cultures in 60% porosity scaffolds; (G–L) results for static
(G–I) and dynamic (J–L) cultures in 80% porosity scaffolds. Cells were able to attach to scaffolds, as shown by H&E staining for (A and D) 60% porosity and (G and J) 80%
porosity scaffolds. Cells produced proteoglycans, detected by toluidine blue staining, either in (B and E) 60% porosity or in (H and K) 80% porosity scaffolds. Sulphated
proteoglycans were detected by alcian blue staining, again for both (C and F) 60% porosity and (I and L) 80% porosity scaffolds. Two magnifications (10" and 20") were used
in each staining for microscopic observation. Scale bar = 100 lm.
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a fibrous cartilage tissue, in either static (Fig. 5B and C) or stirred
culture conditions (Fig. 5E and F). Fibrocartilage is a mixed matrix
consisting of fibrous tissue and hyaline cartilage. It contains type I
and type II collagen and aggrecan [40]. However, hyaline cartilage
contains type II collagens and proteoglycans, the major one being
aggrecan molecule [40]. Cartilage-like tissue formed in 80 CPBS
scaffolds did not presented significant staining of collagen type I
(Fig. 5H and K) yet showed marked staining for collagen type II,
indicating that these tissue properties are more similar to hya-
line-like cartilage tissue, than those obtained with 60 CPBS scaf-
folds. However, GAG content present in 80 CPBS scaffolds was
lower compared with that obtained for 60 CPBS scaffolds (Fig. 6).
This result seems to contradict the previous ones, going in the
direction of the first series of results, where smaller pores enhance
proteoglycan deposition [36,37]. In fact, the opposite effect of pore
size was observed in this work. On the one hand, large pores in-
duced cell proliferation, production of proteoglycans and collagens.
On the other hand, GAG production was significantly lower in scaf-
folds with large pore sizes. Additionally, stirred culture conditions
seem also to affect GAG production for both types of scaffold. In
general, it was observed that stirred conditions enhance GAG pro-
duction. A similar observation was reported by Freyria et al., using
3D collagen scaffolds seeded with BAC and cultured under static or
stirred conditions. Thus, authors state that these conditions allow a
homogeneous distribution of cells and ECM within scaffolds struc-
ture to be obtained [41]. It is described in the literature that sub-
strate geometry and porosity may both influence chondrocyte
behaviour [36,37,42]. Understanding the impact of biomaterial
Fig. 5. Immunolocalization of collagens in CPBS scaffolds, at 4 weeks of culture: (A–F) results for (A–C) static and (D–F) dynamic cultures in 60% porosity scaffolds; (G–L)
results for (G–I) static and (J–L) dynamic cultures in 80% porosity scaffolds. Controls (A, D, G, and J) were performed with normal goat serum. Collagen type I (B–K) and
collagen type II (C–L) were detected. Two magnifications (10" and 20") were used in each staining for microscopic observation. Scale bar = 100 lm.
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geometry is very important for enhancing the in vivo ECM forma-
tion. Many factors may act in concert, such as fluid flow to enhance
nutrition and waste product removal, as well as number of at-
tached cells and their ability to produce ECM [31]. Therefore, the
optimal conditions for each scaffold must be determined, because
each scaffold’s characteristics determine the cell attachment,
growth, maintenance of phenotype and ECM production [34]. Rel-
evant characteristics include scaffold texture, porosity (size, struc-
ture, distribution) and surface free energy [34]. In summary, every
parameter by itself is important and should be considered, but the
overall nature of the relevant parameters makes the scaffold func-
tional and suitable for cartilage tissue engineering.
5. Conclusion
CPBS scaffolds were produced by compression moulding fol-
lowed by salt leaching. Two different types of NaCl salt particles
were used as porogens, and two types of scaffolds with different
porosities, pore geometry and sizewere produced. The 80CPBS scaf-
folds presented larger, randomly structured pores, in contrast to the
60 CPBS scaffolds, which showed smaller pores with a cubic struc-
ture. From the present observations, one can state that 80 CPBS scaf-
folds seemmore effective in inducing ECM production by BACs. The
pore size and geometry of the pore had an effect on cell proliferation
and ECM production. Proteoglycans and collagen type II were de-
tected in larger quantities in 80 CPBS scaffolds (large pores, random
structure) compared with 60 CPBS scaffolds (small pores, cubic
structure). Nevertheless, the amount of glycosaminoglycan was
lower in the 80 CPBS scaffolds. Large pores affected GAG production
in either static or dynamic culture conditions. As regards the culture
conditions, stirred conditions improved ECM production in both
types of scaffold, thus being preferable to static culture conditions.
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Appendix A. Figures with essential colour discrimination
Certain figures in this article, particularly Figures 4 and 5, are
difficult to interpret in black and white. The full colour images
can be found in the on-line version, at doi: 10.1016/
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